Yes

No description available.

This study identifies and analyzes factors which determine productivity in the drug industry. It shares a general concern about recent decline in industrial productivity in the United States with Abernathy, Clark, and Kantrow (1983), who developed a theoretical framework for analyzing the causes of lackluster industrial performance. According to Abernathy, et al. (1983), performance is determined by government fiscal and monetary policy, production capability, socioeconomic environment,(of which regulation is a subset), and corporate management. This study finds that the theoretical framework of Abernathy et al (1983) can be used as a context for analyzing productivity in the drug industry. In a recent case of drug development, socioeconomic and managerial problems caused costly delays in development, hampering the company's capacity to be productive. The study also finds that the strategy for industrial revitalization developed by Abernathy et al. (1983) is applicable to the drug industry. Specifically, corporate management must integrate the development activities of innovation, production, finance, and marketing more efficiently. More efficient integration will help management to consider the impact of one activity on the others, and to identify deficiencies which can delay development. This will help management cut development time and increase profits, which will help revitalize the drug industry. / Master of Science

Liu Shuo. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 120-126). / Abstracts and questionnaires in English and Chinese. / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Chinese Pharmaceutical Industry --- p.5 / Chapter 1.1.1 --- Distributors / Chapter 1.1.2 --- Suppliers´ؤPharmaceutical Manufacturers / Chapter 1.1.3 --- Retailers / Chapter 1.1.4 --- The Public Bidding for Medicines / Chapter 1.2 --- Methodology --- p.18 / Chapter Chapter 2 --- Literature Review / Chapter 2.1 --- The Definition of Guanxi --- p.21 / Chapter 2.2 --- Guanxi and Social Capital --- p.23 / Chapter 2.3 --- Guanxi in Chinese Business Domain --- p.29 / Chapter 2.4 --- Guanxi Practice --- p.33 / Chapter 2.5 --- Theoretical Framework --- p.36 / Chapter Chapter 3 --- Pre-existing Personal Relations / Chapter 3.1 --- Case Selection --- p.42 / Chapter 3.2 --- Functions of Pre-existing Ties --- p.43 / Chapter 3.2.1 --- Preparation of Guanxi Establishment一Information Gathering / Chapter 3.2.2 --- Pre-existing Ties and Information Gathering / Chapter 3.2.3 --- Establish Familiarity / Chapter 3.2.4 --- Pre-existing Ties and Familiarity Establishment / Chapter 3.2.5 --- Limitation of Pre-existing Ties' Effect / Chapter 3.2.6 --- Pre-existing Ties and Guanxi Cultivation / Chapter 3.3 --- Summary --- p.70 / Chapter Chapter 4 --- Guanxi Cultivation / Chapter 4.1 --- Guanxi Practice and Economic Performance --- p.72 / Chapter 4.2 --- Regulations and Prevalence of Guanxi Practice --- p.74 / Chapter 4.3 --- Guanxi Cultivation´ؤChoose Proper Guanxi Practice --- p.76 / Chapter 4.4 --- The Importance of Renqing --- p.78 / Chapter 4.5 --- Socio-economic Environment Change and Guanxi Practice Adjustments --- p.81 / Chapter 4.6 --- Summary --- p.83 / Chapter Chapter 5 --- Quantitative Analysis / Chapter 5.1 --- Hypotheses --- p.86 / Chapter 5.2 --- Conceptualization and Operationalization of Variables --- p.88 / Chapter 5.3 --- Methods --- p.91 / Chapter 5.4 --- Results --- p.92 / Chapter 5.4.1 --- Pharmaceutical Distributors' Organizational Performance / Chapter 5.4.2 --- Pharmaceutical Salespersons' Individual Performance / Chapter 5.5 --- Summary --- p.103 / Chapter Chapter 6 --- Conclusion and Discussion / Chapter 6.1 --- The Study --- p.104 / Chapter 6.2 --- Summary of Findings --- p.105 / Chapter 6.3 --- Theoretical Implications --- p.118 / Chapter 6.4 --- Practical Implications --- p.110 / Chapter 6.5 --- Limitations and Suggestions for Future Research --- p.111 / Appendix I Interview Schedule --- p.113 / Appendix II Sample of Questionnaire --- p.115 / Bibliography --- p.120

Thesis (M.B.A.)--University of North Carolina Wilmington, 2009. / Title from PDF title page (February 23, 2010) Includes bibliographical references (p. 54-57)

by Ma Pui Yin, Flora. / Thesis (M.B.A.)--Chinese University of Hong Kong, 1993. / Includes bibliographical references (leaf 62). / Chapter I. --- INTRODUCTION / The Company Background --- p.1 / The Appeal of PRC --- p.3 / Scope and Objectives --- p.5 / Structure of the Paper --- p.5 / Chapter II. --- METHODOLOGY / Michael Porter's Model --- p.7 / Evaluation of Porter's Model --- p.8 / Lessons from Case Studies --- p.14 / Chapter III. --- INDUSTRY ANALYSIS / Intensity of Rivalry Among Existing Competitors --- p.15 / Threat of New Entrants --- p.21 / Threat of Substitutes --- p.32 / Bargaining Power of Buyers --- p.33 / Bargaining Power of Suppliers --- p.35 / Summary --- p.35 / Chapter IV. --- COMPETITIVE STRATEGY / Entry Strategy --- p.38 / Portfolio Strategy --- p.41 / Targeting Strategy --- p.44 / Alliance Strategy --- p.46 / Chapter V. --- CONCLUSION --- p.49 / APPENDIX --- p.53 / REFERENCES --- p.62

University of Macau / Institute of Chinese Medical Sciences

University of Macau / Institute of Chinese Medical Sciences

University of Macau / Institute of Chinese Medical Sciences

Zugl.: Berlin, Humboldt-University, Diss., 2008. / Includes bibliographical references.